Innovative therapy that ‘tricks’ and destroys cancer cells advance to clinical trial
Results from pre-clinical research show iron-like compound hold promise for treating patients with glioblastoma, an aggressive brain cancer
Results from pre-clinical research show iron-like compound hold promise for treating patients with glioblastoma, an aggressive brain cancer
The brand Azmarda fits well with JBCPL's overall strategy of strengthening its presence in the cardiology segment in India.
The plant is scheduled to come on stream in September 2024
India accounts for more than half (almost 60%) of new leprosy cases worldwide, despite being declared ‘leprosy-free’ in 2005.
Launched in the year 2018, MedEngage Scholarship Program is aimed at nurturing and nourishing medical talent in India
Recommendation is based on pivotal data from the phase III POLARIX study
The study was published recently in Genome Medicine, a leading international journal focused on translational, genomic-based medicine
This investment will help BSV avoid carbon dioxide emissions by as much as 6560 tonnes of carbon dioxide equivalent (tCO2e) annually over its project life of 25 years
Aducanumab collaboration to convert from Eisai sharing of global profits and losses to a global royalty arrangement, effective January 1, 2023
A total of 49 projects have been approved so far for 33 critical APIs with a committed investment of Rs 3,685 crore
        Subscribe To Our Newsletter & Stay Updated